Literature DB >> 11290795

Fibronectin binding protein A of Staphylococcus aureus can mediate human T lymphocyte adhesion and coactivation.

Y J Miyamoto1, E R Wann, T Fowler, E Duffield, M Höök, B W McIntyre.   

Abstract

The extracellular matrix protein fibronectin (FN) mediates the adhesion of bacteria as well as T lymphocytes. Mammalian cells express integrins alpha(4)beta(1) and alpha(5)beta(1) as the major FN-binding cell surface receptors. Bacteria such as Staphylococcus aureus, also express FN-binding receptors that are important for adherence to host tissue and initiation of infection. The S. aureus FN-binding protein, FnbpA, has been previously identified, and recombinant proteins that correspond to distinct functional regions of this protein have been made. Three recombinant truncated forms of FnbpA, rFnbpA(37-881), rFnbpA(37-605), and rFnbpA(620-881), were examined for effects on in vitro adhesion and coactivation of human T lymphocytes. These proteins, when coimmobilized with anti-CD3 mAb, activated T lymphocyte proliferation. The coactivation signal generated by the rFnbpA proteins required medium containing serum with FN. Furthermore, the costimulatory signal could be restored in FN-depleted serum when the rFnbpAs were preloaded with soluble FN. Monoclonal Ab blocking studies revealed that integrin alpha(5)beta(1) is the major receptor responsible for the rFnbpA costimulatory signal. Shear flow cell detachment assays confirmed that lymphocytes can bind to FN captured by the rFnbpA proteins. These results suggest that the S. aureus rFnbpA can interact with integrin alpha(5)beta(1) via an FN bridge to mediate adhesion and costimulatory signals to T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290795     DOI: 10.4049/jimmunol.166.8.5129

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin.

Authors:  Eric L Brown; M Gabriela Bowden; Rebecca S Bryson; Kristina G Hulten; Andrea S Bordt; Andrea Forbes; Sheldon L Kaplan
Journal:  Clin Vaccine Immunol       Date:  2008-11-12

2.  Analysis of Ebh, a 1.1-megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus.

Authors:  Simon R Clarke; Llinos G Harris; R Geoff Richards; Simon J Foster
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Expression of the biofilm-associated protein interferes with host protein receptors of Staphylococcus aureus and alters the infective process.

Authors:  Carme Cucarella; M Angeles Tormo; Erwin Knecht; Beatriz Amorena; Iñigo Lasa; Timothy J Foster; José R Penadés
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function.

Authors:  Matthias Grundmeier; Muzaffar Hussain; Petra Becker; Christine Heilmann; Georg Peters; Bhanu Sinha
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

5.  B-Raf regulation of integrin α4β1-mediated resistance to shear stress through changes in cell spreading and cytoskeletal association in T cells.

Authors:  Wells S Brown; Jahan S Khalili; Tania G Rodriguez-Cruz; Greg Lizee; Bradley W McIntyre
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

6.  Functional blocking of Staphylococcus aureus adhesins following growth in ex vivo media.

Authors:  Ruth C Massey; Shobana R Dissanayeke; Brian Cameron; David Ferguson; Timothy J Foster; Sharon J Peacock
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300.

Authors:  E L Brown; O Dumitrescu; D Thomas; C Badiou; E M Koers; P Choudhury; V Vazquez; J Etienne; G Lina; F Vandenesch; M G Bowden
Journal:  Clin Microbiol Infect       Date:  2008-12-22       Impact factor: 8.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.